🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

28 recruiting trials

for Atherosclerotic Cardiovascular Disease (ASCVD)

Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study) NCT06960902NA9 sites📍 Dijon📍 Lille📍 Lyon Nantes University Hospital · Tests: Coronary CT scan with CAC score measurement Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction NCT07311330Phase 21 site📍 Beijing Beijing Inno Medicine Co., Ltd. · Tests: YN001 20mg Dose + 5% glucose injection, 5% glucose injection Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis NCT07303777Phase 233 sites📍 Beverly Hills📍 San Diego📍 Torrance Atom Therapeutics Co., Ltd · Tests: ABP-745 Dose A, Placebo, ABP-745 Dose B, ABP-745 Dose C ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography NCT06676280Phase 432 sites📍 Anyang📍 Anyang📍 Bucheon-si Jung-min Ahn · Tests: Aspirin, High-intensity statin, Guideline-directed statin therapy Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus NCT06767774Phase 41 site📍 Seoul Korea University Anam Hospital · Tests: Combination therapy, High intensity statin monotherapy Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) NCT05485961Phase 2, Phase 3566 sites📍 Decatur📍 Huntsville📍 Montgomery CSL Behring · Tests: CSL300, Placebo Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia NCT07034690Phase 41 site📍 Abu Dhabi Novartis Pharmaceuticals · Tests: Educational Material, Standard of care Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data NCT07743021n/a33 sites📍 Balatonfüred📍 Békéscsaba📍 Budapest Center for Molecular Fingerprinting Research Nonprofit LLC Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management NCT07208331n/a1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients NCT07542860n/a1 site📍 Beijing Peking University First Hospital Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD NCT07524101NA1 site📍 Seoul Yonsei University · Tests: Moderate-intensity statin and ezetimibe combination therapy, High-intensity statin monotherapy A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event NCT07783802Phase 246 sites📍 Huntsville📍 Tucson📍 Tucson Eli Lilly and Company · Tests: Clazakizumab, Placebo Penn Medicine Healthy Heart NCT06062394NA1 site📍 Philadelphia University of Pennsylvania · Tests: Penn Med Healthy Heart Program Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients? NCT06471036NA1 site📍 Minneapolis Duke University · Tests: Care Champion Intervention LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD) NCT05765370NA1 site📍 Beijing China National Center for Cardiovascular Diseases · Tests: Achieving a Target LDL-C level of 25mg/dL≤ LDL-C<70mg/dL, Achieving a Target LDL-C level of 70mg/dL≤ LDL-C<100mg/… The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study NCT07315997n/a3 sites📍 Boston📍 Boston📍 Boston Brigham and Women's Hospital · Tests: high sensitivity cardiac troponin ASCVD Management Using CCTA in Prostate Cancer Patients on ADT NCT05879913NA3 sites📍 Carmel📍 Indianapolis📍 Indianapolis Indiana University · Tests: Coronary CT Angiography (CCTA) Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease NCT07334834NA1 site📍 Aurora Colorado Prevention Center · Tests: Algorithm- and multi-professional team-supported lipid management, Guideline-directed lipid management by usual care pr… Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE NCT07594392n/a1 site📍 Memphis St. Jude Children's Research Hospital · Tests: Coronary Artery Calcium Scan, Carotid Artery Ultrasound, Lipoprotein(a) Measurement, Vascular Function Testing Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention NCT07581808Phase 41 site📍 Ljubljana University Medical Centre Ljubljana · Tests: Inclisiran, Alirocumab Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease NCT06930885Phase 313 sites📍 Maceió📍 Messejana📍 Petrolina Hospital do Coracao · Tests: Cardiovascular Polypill (Valsartan, Atorvastatin, Aspirin), Colchicine 0.5 mg, Usual Care Group, Colchicine-placebo 0.5… TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD NCT07487363Phase 1, Phase 21 site📍 Shenzhen Hudson Biotech · Tests: TB-500, Placebo A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event NCT07000357Phase 31452 sites📍 Athens📍 Birmingham📍 Birmingham AstraZeneca · Tests: AZD0780, Placebo A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C) NCT07428473Phase 13 sites📍 Clayton📍 Papatoetoe📍 Christchurch Monash University · Tests: STX-1150 A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease NCT07551492Phase 31 site📍 Beijing Fujian Shengdi Pharmaceutical Co., Ltd. · Tests: HRS9531, HRS9531 placebo Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) NCT07157774Phase 3804 sites📍 Birmingham📍 Apache Junction📍 Gilbert Eli Lilly and Company · Tests: Muvalaplin, Placebo Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia NCT06858332n/a20 sites📍 Chelyabinsk📍 Chelyabinsk📍 Kaluga Novartis Pharmaceuticals · Tests: Atorvastatin, Simvastatin, Rozuvastatin, Ezetimibe, Niacin LDL Cholesterol Reduction Following Ezetimibe Initiation NCT07839741Phase 41 site📍 Porto Universidade do Porto · Tests: Ezetimibe
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy